InSitu Biologics, Inc — Form D/A
InSitu Biologics, Inc of Oakdale, MN, a company, filed a Form D amendment with the SEC on 2018-03-07. The offering totals $1.0M. Industry: Pharmaceuticals.
Offering
- Filed: 2018-03-07
- Form: D/A
- Accession: 0001723443-18-000002
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $1.0M
- Remaining: $1.0M
- Minimum investment: $50K
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-300263
Issuer
- Name: InSitu Biologics, Inc
- CIK: 0001723443
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 3510 Hopkins Place N., Oakdale, MN, 55128
- Phone: 651-337-4799
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| James Knapp | Executive Officer | Chicago, IL |
| Jim Segermark | Executive Officer | Woodbury, MN |
| Kevin Barrett | Executive Officer | San Carlos, CA |
| Bill Taylor | Executive Officer | Oakdale, MN |
| Robert Wilson | Director | Oakdale, MN |
| Greg Van Guilder | Director | Golden Valley, MN |
| Daniel Halpern | Director | Oakdale, MN |
| Daniel Halpern | Executive Officer | Oakdale, MN |
| Sandi Klemann | Executive Officer | Oakdale, MN |
| Ivan Shaw | Director | Oakdale, MN |
| Buzz Benson | Director | WORCESTER, MA |
| James Knapp | Director | Chicago, IL |
| Kevin Bassett | Director | Eden Prairie, MN |
| Kevin Bassett | Executive Officer | Eden Prairie, MN |
| Mark Ereth | Executive Officer | Oakdale, MN |
| Kay Warnott | Executive Officer | Oakdale, MN |
| Andy LaFrence | Director | Oakdale, MN |
Other filings by this issuer (5)
More